Verity Rawson currently serves as the Senior International Medical Director at Novo Nordisk, where she leverages over 20 years of extensive experience in clinical development and the medical industry. In her pivotal role, Verity is at the forefront of advancing novel mRNA interference therapies, overseeing...
Verity Rawson currently serves as the Senior International Medical Director at Novo Nordisk, where she leverages over 20 years of extensive experience in clinical development and the medical industry. In her pivotal role, Verity is at the forefront of advancing novel mRNA interference therapies, overseeing the strategic planning and execution of clinical trials from Phase I through Phase IV. Her expertise in formulary access and global strategy allows her to navigate complex regulatory landscapes, ensuring that innovative therapies reach patients efficiently and effectively.
Verity's leadership is characterized by her ability to create high-performing teams that excel in data analysis and medical education. She is adept at fostering collaboration across multidisciplinary groups, enhancing the overall quality of clinical research and ensuring alignment with corporate objectives. Her strong presentation skills enable her to communicate complex medical concepts clearly, making her a sought-after speaker in industry forums.
In addition to her technical skills, Verity is committed to mentoring emerging leaders in the field, emphasizing the importance of line management and effective communication in clinical development. Her contributions have not gone unnoticed; she has received multiple company awards for her dedication and impact on project success. As she continues to drive innovation at Novo Nordisk, Verity remains focused on improving patient outcomes through the development of cutting-edge therapies, making her a key player in the evolving landscape of medicine.
